Twenty patients with chronic pancreatitis and signs of biliary obstruction were treated by endoscopic placement of self expandable metal mesh stents, and followed up prospectively. Eleven had been treated previously with plastic endoprostheses. All 
About 20% of patients with chronic pancreatitis (CP) develop common bile duct (CBD) stenosis and subsequent cholestasis or jaundice.1`S As biliary obstruction can lead to secondary biliary cirrhosis or recurrent episodes of cholangitis, surgical treatment has been recommended for stricture associated with persistent cholestasis. [3] [4] [5] Endoscopic biliary drainage using large plastic (Fig 1) . Two patients (10%) developed epithelial hyperplasia within the stent resulting in recurrent cholestasis for one and jaundice for the other, three and six months after stent placement, respectively (Fig  4) . A second self expanding stent was inserted into the first stent in each case without longterm success, as obstruction occurred again after three months in both. We then placed two plastic 10 French stents through the metallic stent. One of these patients (Table; patient nnn M n E n n n n i16 1 4 hepaticojejunostomy, which was performed without any problem related to the stent in place. All patients (90%) who were free of obstruction from hyperplasia six months after implantation, remained Placement of large bore plastic biliary stents was a good initial treatment for cholangitis or jaundice when present. Longterm results, however, were unsatisfactory because of clogging or dislodgement, and required frequent replacement, which is not acceptable to these often young patients.2 Our opinion at that time was that permanent endoscopic biliary drainage in CP should be reserved for patients whose poor clinical condition made an operation unsuitable.
Self expandable biliary stents have been used for palliative treatment of malignant biliary strictures. All the published results available at this time show that this new material is easy to place and avoids most of the early stent related complications -that is, early clogging or dislodgement."' '5 The internal diameter of these stents is 10 mm, which is three times the diameter of the largest plastic stents. To our knowledge, early clogging or dislodgement has not been reported. The initial enthusiasm concerning longterm patency of these stents in malignancies, however, has diminished because of frequent obstruction because of tumour ingrowth through the metallic struts, or tumour overgrowth.91' As obstruction in these cases is because of the tumoral process itself, we postulated that their longterm patency in benign biliary strictures was likely to be better. This was suggested by a report of the preliminary results ofmesh stent implantation in postsurgical biliary stenosis. With an average follow up of eight months, no cases of reobstruction were seen in seven patients.14 These results are, however, probably too optimistic as a few cases of reocclusion by hyperplasia through the mesh have been reported with metallic stents placed either percutaneously9' 1 or endoscopically (C Liguory, personal communication) for postsurgical CBD strictures.
We chose to treat patients with CP associated biliary strictures with these devices for two reasons. The first is that we have a large number of patients with a good follow up in our institution and we are reluctant to propose surgery only for biliary diversion when there is not yet an indication for pancreatic drainage, as repeated surgery is associated with higher morbidity. The second is that the CBD stricture is always distal allowing for the use of comparatively short (34 mm) mesh stents.
Indeed, as these stents are not removable and because we are treating patients with benign disease, we did not want to compromise a potential surgical biliary diversion. As the stent is left in the distal part of the CBD, a future hepaticojejunostomy or choledochoduodenostomy still remains possible as was shown in one of our patients.
The potential for malignant transformation at the site of implantation as a result of chronic irritation from the metal remains a theoretical problem worthy of consideration. Clearly, this study cannot provide a definitive answer. Surgeons, however, have used metallic implants such as clips and automatic sutures for a long time without any such complication reported.'6 It seems therefore that implanted metal despite a potential to induce fibrosis or inflammation, has not been responsible for malignancy. Also reassuring are animal studies in which these stents have shown excellent biological tolerance and no dysplastic changes have been noted. 17 Ninety per cent of stents remain patent at three years and when abnormal hyperplasia occurs, resulting in stent occlusion, it occurs during the first six months. Two of our 20 patients required further biliary drainage. Epithelial hyperplasia is a constant finding in the presence of these stents, probably resulting from mechanical irritation. The reason why it becomes more pronounced in some patients remains unanswered. In the two cases of reobstruction, the pattern mimicked the previous stricture, suggesting that the radial force exerted by the mesh on the wall may have led to deeper embedding of the mesh where the stricture was tight or may have provoked more important hyperplasia, or both. This may partially explain the better results seen here compared with those obtained with metal stents in postsurgical strictures. '5 In these cases, the stricture is short and tight and the radial force exerted by the individual wires at the level of the stricture is therefore higher.
The lower end of the stent must be level with the papilla to avoid the presence of metallic mesh within the duodenum and must extend over the entire stricture. In the event of misplacement, as we saw in one patient, immediate removal is possible. Where there is sharp angulation of the CBD, the upper part of the stent should be 1 cm above or 1 cm below the angulation, but not at the point of angulation itself, to avoid impaction of the metallic mesh in the CBD wall and possibly further impaired drainage.
Within a month of placement, the metallic mesh embeds into the bile duct wall and, after three months, the struts are buried by the mucosa, giving the impression of a continuous membrane covering the inner stent. This finding is comparable with animal studies,'7 where implantation of metal stents is followed by mucosal hyperplasia through the space between the struts, which finally are buried by the mucosa. This finding is suggestive of destruction of the original mucosal layer during expansion with subsequent healing and proliferation. 'Clogging' ofthese stents by material comparable with the one seen in plastic stents has not been seen, probably because of both a larger diameter of the lumen and the nature of the stent's inner lining after re-epithelialisation.
Longer follow up and possibly controlled clinical trials are needed to determine if metal stents have the potential to become the first choice treatment for persistent, symptomatic CP associated biliary stricture. This study suggests, however, that there may be a satisfactory low morbidity alternative to biliary surgery providing efficient prolonged biliary drainage, without the usual complications and discomfort associated with plastic stents.
